- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/04 - Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Patent holdings for IPC class A61P 1/04
Total number of patents in this class: 3351
10-year publication summary
|
117
|
118
|
158
|
238
|
243
|
292
|
230
|
256
|
231
|
80
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2703 |
71 |
| Daiichi Sankyo Company, Limited | 1848 |
54 |
| AstraZeneca AB | 2933 |
52 |
| Osaka University | 3350 |
28 |
| Ono Pharmaceutical Co., Ltd. | 427 |
24 |
| The Regents of the University of California | 19780 |
21 |
| Ajinomoto Co., Inc. | 2300 |
21 |
| Janssen Biotech, Inc. | 1505 |
21 |
| Raqualia Pharma Inc. | 122 |
21 |
| Eisai R&D Management Co., Ltd. | 1233 |
21 |
| Astellas Pharma Inc. | 1082 |
19 |
| Dainippon Sumitomo Pharma Co., Ltd. | 200 |
19 |
| Taisho Pharmaceutical Co., Ltd. | 854 |
19 |
| Daewoong Pharmaceutical Co., Ltd. | 313 |
18 |
| The University of Tokyo | 4129 |
18 |
| Cedars-Sinai Medical Center | 1135 |
17 |
| Mitsubishi Tanabe Pharma Corporation | 581 |
16 |
| Meiji Co., Ltd. | 710 |
15 |
| Chugai Seiyaku Kabushiki Kaisha | 1330 |
14 |
| Nippon Shinyaku Co., Ltd. | 328 |
14 |
| Other owners | 2848 |